KRISTOFFER ANCHO: Open Payments
NPI 1700199205 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 37 payments from 11 companies in 2025. Trend: 2023 $1,018 · 2024 $623 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $178 |
| Janssen Pharmaceuticals, Inc | 6 | $175 |
| Axsome Therapeutics, Inc. | 4 | $162 |
| Lundbeck LLC | 6 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $118 |
| Lilly USA, LLC | 3 | $56 |
| ABBVIE INC. | 2 | $46 |
| SCILEX PHARMACEUTICALS INC. | 2 | $38 |
| Eisai Inc. | 1 | $29 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: REXULTI, SPRAVATO, Auvelity, INGREZZA, KISUNLA, UBRELVY, ZTLido, Leqembi.
Industry payments across CA — which companies pay providers there.
